SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it has combined its Life Sciences Group with its Diagnostics and Genomics business, naming Lars Holmkvist the new group’s president and senior vice president of Agilent, effective immediately. Holmkvist was previously president of the Diagnostics and Genomics Group and senior vice president of Agilent. […]
CARLSBAD, Calif. — Life Technologies Corporation (NASDAQ: LIFE) today announced that the Dow Jones Sustainability Index (DJSI) has named the company the 2013 Life Sciences Tools & Services industry sector leader, and the only life sciences company listed on both the DJSI North America and World Indexes. The DJSI leaders are chosen from among the […]
“SensiQ Technologies has received Phase I funding from the National Institutes of Health to develop a next generation surface plasmon resonance-based platform,” said David Goad, PhD, Research Scientist for SensiQ Technologies and Principal Investigator for the research. “We anticipate this project will result in new, state-of-the-art SPR biosensing technology with applications in a number of […]
PLYMOUTH, MI — The National Institute Of General Medical Sciences of the National Institutes of Health issued a Notice of Award granting a Fast-Track Small Business Investigational Research (SBIR) Phase I and Phase II grant of $2.0 million for Advaita to develop biological pathway analysis tools for personalized medicine and drug repositioning. The three and […]
Mountain View, CA — Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH). The grant – $5.25 […]
Boston, MA: 908 Devices, an innovator in point-of-need chemical analysis, today announced that it received $7M in Series B funding, which included new investment from Schlumberger and follow-on investments from ARCH Venture Partners, Razor’s Edge Ventures and University of Tokyo Edge Capital (UTEC). In addition, 908 Devices and Schlumberger signed a technical collaboration and development […]
LANCASTER, Calif. — Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today released preliminary revenues for its fourth fiscal quarter and fiscal year 2013, ended August 31, 2013 (4QFY13). Ms. Momoko Beran, chief financial officer of Simulations Plus, stated, “In accordance with our policy to […]
CINCINNATI — Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2014 sales and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year ending September 30, 2014, management expects net sales to be in the range of $203 to $208 […]
TUCSON, Ariz. – The National Human Genome Research Institute of the National Institutes of Health issued a Notice of Award granting a Phase II SBIR award of $1.01 million for HTG Molecular Diagnostics to continue the Nuclease Probe Mediated Sequencing Project (HTG EdgeSeq). The HTG EdgeSeq program will develop targeted sequencing products that leverage HTG […]
Qlucore has been awarded funding of €0.6 million over a three year period by the European Commission’s 7th Framework Programme as part of a €6.0 million consortium project (Grant n° 601851) for the development of mathematical and statistical algorithms focusing on integrating data from multiple analytical platforms focusing on integrating genetic and proteomic data with […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
